The oncogenetic molecular mechanisms involved in ABC-DLBCL were primarily initiated by BCR subunit activated mutations, as well as the CARD11 and MYD88 mutations, resulting in the constitutive activation of NF-κB [16, 24]. The gene discussed is BCR; the disease is aneurysmal bone cyst.